Posted inIndustrial Project
Abbott Doubles Down on U.S. Manufacturing with New Georgia Facility for Cardiovascular Devices.
Abbott announces a new cardiovascular device manufacturing plant in Georgia for 2028, its second major U.S. investment in 2025. Follows a $500M transfusion diagnostics expansion into a $1B molecular testing market. Second…
